Contrast Media; Crohn Disease/pathology; Humans; Intestines/pathology; Magnetic Resonance Imaging
Abstract :
[en] Crohn's disease is an inflammatory bowel disease that affects mainly young people and includes periods of remission interspersed with occasional flare-ups. Entero-MR (Magnetic Resonance) is a non-radiating and a non-invasive tomography imaging technique. Entero-MR has recently proven its ability to assess inflammatory activity and structural damage of the bowel in Crohn's disease which are fundamental elements in the therapy planning. These considerations explain why entero-MR is playing an increasing role in the evaluation of Crohn's disease.
Maccioni F, Viscido A, Broglia L, et al. Evaluation of Crohn disease activity with magnetic resonance imaging. Abdom Imaging 2000;25:219-8. (Pubitemid 30304973)
Newnham E, Hawkes E, Surender A, et al. Quantifying exposure to diagnostic medical radiation in patients with inflammatory bowel disease: Are we contributing to malignancy? Aliment Pharmacol Ther 2007; 26:1019-24. (Pubitemid 47416293)
Negaard A, Paulsen V, Sandvik L, et al. A prospective randomized comparison between two MRI studies of the small bowel in Crohn's disease, the oral contrast method and MR enteroclysis. Eur Radiol 2007;17:2294- 301. (Pubitemid 47288266)
Ajaj W, Goyen M, Schneemann H, et al. Oral contrast agent for small bowell distension in MRI: Influence of the osmolarity for small bowell distension. Eur Radiol 2005;15:1400-6. (Pubitemid 40983523)
Borthne AS, Abdelnoor M, Storaas T, et al. Osmolarity: A decisive parameter of bowel agents in intestinal magnetic resonance imaging. Eur Radiol 2006;16: 1331-6. (Pubitemid 43834720)
Rimola J, Rodriguez S, Cabanas ML, et al. MRI of Crohn's disease: From imaging to pathology. Abdom Imaging 2012;37:387-96.
Oommen J, Oto A. Contrast-enhanced MRI of the small bowel in Crohn's disease. Abdom Imaging 2011;36:134-41.
Ippolito D, Invernizzi F, Galimberti S. MR enterography with polyethylene glycol as oral contrast medium in the follow-up of patients with Crohn disease: Comparison with CT enterography. Abdom Imaging 2010;35:563-70.
Low RN, Francis IR, Politoske D, et al. Crohn's disease evaluation: Comparison of contrast-enhanced MR imaging and single-phase helical CT scanning. J Magn Reson Imaging 2000;11:127-35. (Pubitemid 30080965)
Siddiki HA, Fidler JL, Fletcher JG, et al. Prospective comparison of state-of-the-art MR enterography and CT enterography in small bowel Crohn's disease. Am J Roentgenol 2009;193:113-21.
Rimola J, Ordas I, Rodriguez S, et al. Colonic Crohn's disease: Value of magnetic resonance colonography for detection and quantification of disease activity. Abdom Imaging 2010;35:422-7.
Rimola J, Orda's I, Rodrigez S, et al. Magnetic resonance imaging for evaluation of Crohn's disease: Validation of parameters of severity and quantitative index of activity. Inflamm Bowel Dis 2011;17:1759-68.
Rimola J, Orda's I, Rodrigez S, et al. Imaging indexes of activity and severity for Crohn's disease: Current status and future trends. Abdom Imaging 2012; 37:958-66.
Van Assche G, Herrmann KA, Louis E, et al. Effects of infliximab therapy on transmural lesions as assessed by magnetic resonance enteroclysis in patients with ileal Crohn's disease. J Crohns Colitis 2013; sous presse.
Benitez JM, Meuwis MA, Reenaers C, et al. Role of endoscopy, cross-sectional imaging and biomarkers in Crohn's disease. Gut 2013; sous presse.
Pariente B, Cosnes J, Danese S, et al. Development of the Crohn's Disease Digestive Damage Score, the Lémann Score. Inflamm Bowel Dis 2011;17:1415-22.
Taylor S A, Punwani S, Rodriguez-Justo M, et al. Mural Crohn disease: Correlation of dynamic contrastenhanced MR imaging findings with angiogenesis and inflammation at histologic examination - Pilot Study. Radiology 2009;251:369-79.
Kiryu S, Dodanuki K, Takao H, et al. Free-breathing diffusion-weighted imaging for the assessment of inflammatory activity in Crohn's disease. J Magn Res Imaging 2009;29:880-6.
Maccioni F, Patak M A, Signore A, et al. New frontiers of MRI in Crohn's disease: Motility imaging, diffusion- weighted imaging, perfusion MRI, MR spectroscopy, molecular imaging, and hybrid imaging (PET/MRI). Abdom Imaging 2012;37:974-82.
Zappa M, Vilgrain V. Intérêt de l'entéro-IRM dans la maladie de Crohn. Colon Rectum 2009;3:84-9.
Horsthuis K, Bipat S, Stokkers P, et al. Magnetic resonance imaging for evaluation of disease activity in Crohn's disease: A systematic review. Eur Radiol 2009; 19:1450-60.
Maccioni F. Introduction to the Feature Section on Crohn's disease activity: MRI assessment and clinical implications;. Abdom Imaging 2012;37:917-20.
Griffin N, Grant LA, Anderson S. Small bowel MR enterography: Problem solving in Crohn's disease. Insights Imaging 2012;3:251-63.
Papanikolaou N, Gourtsoyianni S. MRI of the Small Bowel: Enteroclysis. In: Stoker J (ed) - MRI of the gastrointestinal tract. Berlin/Heidelberg/New York: Springer, 2010;135-148.
Malago R, Manfredi R, Benini L, et al. Assessment of Crohn's disease activity in the small bowel with MRenteroclysis: Clinico-radiological correlations. Abdom Imaging 2008;33:669-75.
Masselli G, Vecchioli A, Gualdi G F. Crohn disease of the small bowel: MR enteroclysis versus conventional enteroclysis. Abdom Imaging 2006;31:400-9. (Pubitemid 46352049)
Rieber A, Wruk D, Potthast S, et al. Diagnostic imaging in Crohn's disease: Comparison of magnetic resonance imaging and conventional imaging methods. Int J Colorectal Dis 2000;15:176-81.